Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $295.7 million.

  • Select Medical Holdings' Free Cash Flow fell 620.25% to $122.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.0 million, marking a year-over-year decrease of 5063.58%. This contributed to the annual value of $295.7 million for FY2024, which is 1620.23% down from last year.
  • Select Medical Holdings' Free Cash Flow amounted to $295.7 million in FY2024, which was down 1620.23% from $352.9 million recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Free Cash Flow ranged from a high of $881.6 million in FY2020 and a low of $94.5 million during FY2022
  • Its 5-year average for Free Cash Flow is $369.1 million, with a median of $295.7 million in 2024.
  • As far as peak fluctuations go, Select Medical Holdings' Free Cash Flow plummeted by 7496.79% in 2021, and later soared by 27358.05% in 2023.
  • Select Medical Holdings' Free Cash Flow (Annual) stood at $881.6 million in 2020, then crashed by 74.97% to $220.7 million in 2021, then crashed by 57.2% to $94.5 million in 2022, then skyrocketed by 273.58% to $352.9 million in 2023, then decreased by 16.2% to $295.7 million in 2024.
  • Its Free Cash Flow stands at $295.7 million for FY2024, versus $352.9 million for FY2023 and $94.5 million for FY2022.